Cargando…
Monitoring Circulating Tumor DNA in Untreated Non-Small-Cell Lung Cancer Patients
Circulating tumor DNA (ctDNA) has been utilized to monitor the clinical course of patients of non-small-cell lung cancer (NSCLC) who receive therapies targeting druggable mutations. However, despite providing valuable information on how NSCLC would naturally progress, the clinical utility of ctDNA f...
Autores principales: | Ryu, Woo Kyung, Oh, Sekyung, Lim, Jun Hyeok, Lee, Seung Jae, Shin, Hyun-Tae, Ryu, Jeong-Seon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455735/ https://www.ncbi.nlm.nih.gov/pubmed/36076922 http://dx.doi.org/10.3390/ijms23179527 |
Ejemplares similares
-
Heterogeneous radiological response to chemotherapy is associated with poor prognosis in advanced non‐small‐cell lung cancer
por: Ryu, Woo Kyung, et al.
Publicado: (2021) -
Effect of whole-brain radiotherapy with platinum-based chemotherapy in non-small cell lung cancer patients with multiple metastases including brain metastases
por: Ryu, Woo Kyung, et al.
Publicado: (2023) -
Gender as an independent prognostic factor in small-cell lung cancer: Inha Lung Cancer Cohort study using propensity score matching
por: Lim, Jun Hyeok, et al.
Publicado: (2018) -
Low-level expression of necroptosis factors indicates a poor prognosis of the squamous cell carcinoma subtype of non-small-cell lung cancer
por: Lim, Jun Hyeok, et al.
Publicado: (2021) -
Small-cell Lung Cancer Presenting as Fatal Pulmonary Hemorrhage
por: Lim, Jun Hyeok, et al.
Publicado: (2018)